Techniques for Avoidance of Sternotomy and Cardiopulmonary Bypass During Resection of Extensive Renal Cell Carcinoma with Vena Caval Tumor Thrombus Extension Above the Diaphragm

2009 ◽  
Vol 24 (6) ◽  
pp. 657-660 ◽  
Author(s):  
Gaetano Ciancio ◽  
Samir P. Shirodkar ◽  
Mark S. Soloway ◽  
Tomas A. Salerno
Keyword(s):  
Renal Cell Carcinoma ◽  
Cardiopulmonary Bypass ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Tumor Thrombus ◽  
Caval Tumor Thrombus

scholarly journals Renal cell carcinoma with vena caval tumor thrombus extending into the right atrium

2006 ◽  
Vol 119 (22) ◽  
pp. 1934-1936 ◽  
Author(s):  
Hai JIANG ◽  
Zhi-gen ZHANG ◽  
Zhao-dian CHEN ◽  
Shi-fang SHI ◽  
Song-liang CAI ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Right Atrium ◽  
Renal Cell ◽  
Tumor Thrombus ◽  
The Right ◽  
Caval Tumor Thrombus

Renal cell carcinoma with an infrarenal vena caval tumor thrombus

Urology ◽  
1999 ◽  
Vol 54 (3) ◽  
pp. 561 ◽  
Author(s):  
Ravi K Mootha ◽  
Rhett Butler ◽  
Rodolfo Laucirica ◽  
Peter T Scardino ◽  
Seth P Lerner
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Tumor Thrombus ◽  
Caval Tumor Thrombus

scholarly journals Surgical Treatment Strategy with Combined Cardiopulmonary Bypass for Renal Cell Carcinoma with Tumor Embolism Developed in Inferior Vena Cava

2020 ◽  
Vol 23 (1) ◽  
pp. E025-E029
Author(s):  
Tomohiro Imazuru ◽  
Masateru Uchiyama ◽  
Tomoki Shimokawa
Keyword(s):  
Renal Cell Carcinoma ◽  
Cardiopulmonary Bypass ◽  
Inferior Vena Cava ◽  
Cell Carcinoma ◽  
Surgical Management ◽  
Renal Cell ◽  
Tumor Thrombus ◽  
Inferior Vena ◽  
Vena Cava ◽  
Significant Difference

Objective: Renal cell carcinoma (RCC) with tumor thrombus in the inferior vena cava (IVC) presents surgeons with a technical intraoperative challenge because of the need for aggressive surgical management. In this study, we describe our method for surgical management with cardiopulmonary bypass (CPB) and investigate the long-term outcomes of RCC patients with and without CPB. Methods: Fifteen patients with RCC underwent nephrectomy and IVC thrombectomy from May 2011 to December 2017. We retrospectively reviewed and analyzed the clinical course of all patients. Novick classification was used to assess the level of tumor thrombus extension into the IVC. Patient characteristics, surgical procedures, and postoperative outcome data in both groups were collected. Results: Twelve patients were male and 3 were female, with an average age of 62.9 ± 10.9 years (range 46 to 82). The average operative times were 824 ± 335 minutes in the patients with CPB and 646 ± 162 minutes in those without CPB (P = .17). The average amount of intraoperative bleeding was 2125 ± 1315 ml in the patients with CPB and 3333 ± 1431 ml in those without CPB (P = .14). The same tendency was observed in patients of Novick levels 3 and 4. The mean observation period was 1061.4 days. No 30-day mortality was noted. There was no significant difference in all-cause survival between the patients with CPB and those without. Conclusions: We conclude that surgical management with CPB and circulatory arrest may be a viable and safe method of treatment for RCC patients.

Normothermic Cardiopulmonary Bypass with Beating Heart for Management of Renal Cell Carcinoma with Atrial Tumor Thrombus

2013 ◽  
Vol 8 (4) ◽  
pp. 316-319
Author(s):  
Domenico Calcaterra ◽  
Thomas E. Collins ◽  
Joseph W. Turek ◽  
Kalpaj R. Parekh ◽  
Mohammad Bashir ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cardiopulmonary Bypass ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Tumor Thrombus ◽  
Beating Heart ◽  
Atrial Tumor
Sign in / Sign up

Export Citation Format

Share Document